[Value of serum alpha 1-antitrypsin in prostate pathology]. 1986

J Morote Robles, and J A de Torres Mateos, and R Jardí Margalef, and J Palou Redorta, and J Aymerich Real, and J Prats López, and A Soler Roselló

UI MeSH Term Description Entries
D008297 Male Males
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000515 alpha 1-Antitrypsin Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Trypsin Inhibitor, alpha 1-Antitrypsin,alpha 1-Protease Inhibitor,alpha 1-Proteinase Inhibitor,A1PI,Prolastin,Serpin A1,Zemaira,alpha 1 Antiprotease,alpha 1-Antiproteinase,1-Antiproteinase, alpha,Antiprotease, alpha 1,Inhibitor, alpha 1-Protease,Inhibitor, alpha 1-Proteinase,Trypsin Inhibitor, alpha 1 Antitrypsin,alpha 1 Antiproteinase,alpha 1 Antitrypsin,alpha 1 Protease Inhibitor,alpha 1 Proteinase Inhibitor

Related Publications

J Morote Robles, and J A de Torres Mateos, and R Jardí Margalef, and J Palou Redorta, and J Aymerich Real, and J Prats López, and A Soler Roselló
February 1996, European journal of cancer (Oxford, England : 1990),
J Morote Robles, and J A de Torres Mateos, and R Jardí Margalef, and J Palou Redorta, and J Aymerich Real, and J Prats López, and A Soler Roselló
January 2012, Urologiia (Moscow, Russia : 1999),
J Morote Robles, and J A de Torres Mateos, and R Jardí Margalef, and J Palou Redorta, and J Aymerich Real, and J Prats López, and A Soler Roselló
November 1976, Pediatria polska,
J Morote Robles, and J A de Torres Mateos, and R Jardí Margalef, and J Palou Redorta, and J Aymerich Real, and J Prats López, and A Soler Roselló
July 1968, The New England journal of medicine,
J Morote Robles, and J A de Torres Mateos, and R Jardí Margalef, and J Palou Redorta, and J Aymerich Real, and J Prats López, and A Soler Roselló
March 1972, Chest,
J Morote Robles, and J A de Torres Mateos, and R Jardí Margalef, and J Palou Redorta, and J Aymerich Real, and J Prats López, and A Soler Roselló
December 1988, The Journal of the Association of Physicians of India,
J Morote Robles, and J A de Torres Mateos, and R Jardí Margalef, and J Palou Redorta, and J Aymerich Real, and J Prats López, and A Soler Roselló
January 1976, Revue medicale de la Suisse romande,
J Morote Robles, and J A de Torres Mateos, and R Jardí Margalef, and J Palou Redorta, and J Aymerich Real, and J Prats López, and A Soler Roselló
February 1986, The Indian journal of medical research,
J Morote Robles, and J A de Torres Mateos, and R Jardí Margalef, and J Palou Redorta, and J Aymerich Real, and J Prats López, and A Soler Roselló
January 1971, Humangenetik,
J Morote Robles, and J A de Torres Mateos, and R Jardí Margalef, and J Palou Redorta, and J Aymerich Real, and J Prats López, and A Soler Roselló
July 1978, Revue medicale de Liege,
Copied contents to your clipboard!